Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Disclosures; Correction
This document contains a correction to the rules relating to the format for nucleotide and/or amino acid sequence disclosures in patent applications.
- Task
- Read the news
- Patent or trademark
- both
- Legacy system
- —
- Current entry point
- www.federalregister.gov/documents/1998/09/10/98-24358/requirements-for-patent-applications-containing-nucleotide-sequence-andor-amino-acid-disclosures (permanent link in the Federal Register, verified 2026-09-30)
- Legacy system and where it moved
- No legacy system name mention in title or summary )
- Fee
- No fee mention in title or summary )
- What you need (account or API key)
- No account or key mention in title or summary )
- Published
- 1998-09-10
- Document type
- Rule
- Source
- USPTO documents published in the Federal Register (Federal Register API)(retrieved 2026-10-06)
Everything in the same category
Read the news (all 1988) · both (all 2333)
Related entry points
- Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Disclosures
- Adoption of Updated WIPO Standard ST.26; Revision to Incorporation by Reference
- Adoption of Updated WIPO Standard ST.26; Revision to Incorporation by Reference
- Electronic Submission of a Sequence Listing, a Large Table, or a Computer Program Listing Appendix in Patent Applications
- Standard ST.26-Request for Comments on the Recommended Standard for the Presentation of Nucleotide and Amino Acid Sequence Listings Using XML (eXtensible Markup Language)
- Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures
- Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures
- Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures
- Submission for OMB Review; Comment Request; “Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures”
- Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures
- Submission for OMB Review; Comment Request; “Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures”
- Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Comment Request; Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures
- Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Comment Request; Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures
- Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures
- Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures
- Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures